AML Resources

Patient Reimbursement

Dedicated specialists are available to assist you or your loved one who has started treatment, in either the inpatient or outpatient setting, with reimbursement for VYXEOS.

Reimbursement hotline 1-855-5VYXEOS (1-855-589-9367) available Monday through Friday, 9 AM to 8 PM ET.

What is VYXEOS?

VYXEOS (daunorubicin and cytarabine) liposome for injection 44 mg/100 mg is an intravenous (IV) chemotherapy used for the treatment of adults with certain types of newly-diagnosed acute myeloid leukemia (AML). These types include patients whose AML is related to previously received chemotherapy or radiation therapy (also called therapy-related AML, t-AML) and AML in patients who previously had certain types of blood disorders (also called AML with myelodysplasia-related changes, AML-MRC).

Important Safety Information

VYXEOS has different dosage recommendations from other medications that contain daunorubicin and/or cytarabine. Do not substitute VYXEOS for other daunorubicin and/or cytarabine-containing products.

Important Safety Information